Adaptations in the behaviours of people who use MDMA shows that they are able, willing and indeed eager to minimise their risk exposure where possible. The demand for stimulants in social environments appears to be resilient more broadly, even in the face of such market shocks. Options for future regulated online sales exist but need to account for problems such as the lack of face-to-face interaction with a vendor (and the potential loss of key tailored harm reduction which can be given in person), and meaningful enforcement of age controls. The pull factors of the darknet in the current illegal market highlight important challenges for a regulated market. This is up from 48.7% in 2015, when the percentage was also higher than for any other dru

While a slight decrease in price was observed in 2022 for ecstasy tablets, this may not be statistically significant or sustained in the coming years. In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing). For countries reporting data in 2022, a considerable retail price range was observed, with prices per ecstasy tablet ranging from EUR 4 to EUR 19 (mean) and prices of MDMA powder from EUR 6 to EUR 50 per gram. Occasionally, tablets containing 250 milligrams or more of MDMA are encountered on EU drug markets. This trend may be a combination of the scheduling of PMK glycidate, and a reduction in demand for MDMA during the COVID-19 pandemic, and is in line with the changes observed in the adulteration of ecstasy tablets (see Section Ecstasy adulteration is responsive to market pressures). This means that the ratio of MDMA to fillers (excipients) in the mixtures used to make ecstasy tablets did not increase over this time period.

In fact, it could be argued that MDMA in the form of ecstasy tablets became cheaper between 2012 and 2019 as tablets containing larger quantities of MDMA became increasingly available on the market (see Section The trend of large tablets containing more MDMA may be reversing

When using wastewater data to estimate MDMA markets, the use of MDMA is based on the excreted parent drug, rather than on an excreted metabolite (which is the case for some other drugs, such as cocaine and heroin


MDMA is reported in small numbers of drug-induced deaths, and in most countries less than 1 in 20 cases involve the drug. While affected by limitations and uncertainties, this type of data analysis shows great promise as a complementary information source to monitor the size and changes in drug markets (Quireyns et al., 2023). It was possible to construct estimates of city-level MDMA market sizes by combining wastewater data with country-level data for average retail purity and price. Demand-based estimates may underestimate the size of drug markets for a number of reasons, including difficulty reaching some groups of users, and underreporting of prevalence and quantities used by respondents. Estimates of amounts used suggest that about 72.4 million ecstasy tablets were consumed in the European Union in 2021. In the case of Belgium, Czechia, France, Luxembourg, Malta, Norway and Portugal, no recent data for last month prevalence of MDMA were reported, so data were impute


This may not reflect use patterns, but rather differences in the offer, legal requirement and access to drug treatment between countries. Almost two thirds (503) of all new treatment entrants were reported from three countries, Germany (213); France (169) and Hungary (121). At EU and country level, people seeking drug treatment for MDMA-related problems represent a very small proportion of all clients entering drug treatment – typically less than 0.5 % of all new entrants into drug treatment in any given yea

From 2004 to 2009, buy ecstasy the proportion of seized European ecstasy tablets that contained MDMA as the only scheduled substance dropped substantially. When availability of MDMA is high, ecstasy tablets tend to contain MDMA as the main or only psychoactive ingredient, with the opposite occurring when there are shortages. Despite this, on average, only a minority of EWSD respondents reported obtaining the drug online, although this varied widely across countries.


Perhaps most obviously it demonstrates, yet again, the futility of putting enforcement, targeting either people who use or supply, at the forefront of the policy response to drugs. The EMCDDA also reported in 2019 that ‘transactions involving quantities of MDMA tablets indicative of the middle level of the market account for more than double the revenue of sales of retail-level quantities’. Prevalence of drug use data tables including general population surveys and wastewater analysis (all substances) Alcohol was co-consumed across 67 % of all MDMA-related hospital emergencies, and the other drugs commonly consumed alongside MDMA included cocaine, amphetamine, methamphetamine, ketamine, heroin, GHB and cannabis. The share of acute drug-toxicity presentations involving MDMA increased as compared to other substances and the previous year (or MDMA was reported for the first time) in 10 of the Euro-DEN hospitals. The majority of drug-induced deaths in Türkiye are among younger people, predominantly males, and are more likely to involve stimulant drugs rather than buy ecstasy opioids, compared with the European Union and Norwa

• 글쓰기

• 수정
• 삭제
• 목록